跳至主要内容
临床试验/IRCT20201012049010N2
IRCT20201012049010N2已完成3 期

Comparison of the effect of the integrated drug- incentive spirometry therapy with drug therapy alone on recovery and mortality of patients admitted to hospital with Covid 19

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Older age equals 18 years
  • Patients with Covid 19 (based on diagnostic methods of the latest published version of the National Protocol)
  • Need to be admitted to a non-intensive care unit
  • Hospitalization in the last 6 hours

排除标准

  • Any case of CNS disorder that interferes with patient communication and educability
  • Need to be admitted to the intensive care unit at the time of enrollment
  • history of lung disease
  • sPo2<94% (at room air)
  • Participation in any other clinical trial of an experimental treatment for COVID-19
  • pregnant woman or man who his spouse is pregnant
  • history of CHF
  • Requiring mechanical ventilation at screening
  • Evidence of multi-organ failure
  • Recent of ACS
  • no willingness for enrollment

研究者

相似试验